Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Amgen
Amgen
Children's Hospital of Philadelphia
Fundación de investigación HM
H. Lee Moffitt Cancer Center and Research Institute
Hoffmann-La Roche
Shanghai Pharmaceuticals Holding Co., Ltd
Ratio Therapeutics, Inc.
Tianjin Medical University Cancer Institute and Hospital
National Institutes of Health Clinical Center (CC)
CEBIOTEX
University of Alabama at Birmingham
Alpha Tau Medical LTD.
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
Novartis
Valent Technologies, LLC
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
City of Hope Medical Center
Esperas Pharma Inc.
Lantern Pharma Inc.
Shandong Cancer Hospital and Institute
Stanford University
Children's National Research Institute
Blueprint Medicines Corporation
North Eastern German Society of Gynaecological Oncology
Mundipharma Research Limited
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Eisai Inc.
Australasian Leukaemia and Lymphoma Group
Beijing Immunochina Medical Science & Technology Co., Ltd.
National Cancer Institute (NCI)
OncoTherapy Science, Inc.
Charite University, Berlin, Germany
Ipsen
Bayer
Sunnybrook Health Sciences Centre
Emory University
Peking Union Medical College Hospital
Eisai Inc.
City of Hope Medical Center
Athenex, Inc.
Bristol-Myers Squibb
Nektar Therapeutics
Atara Biotherapeutics
Centre Hospitalier Universitaire, Amiens
Roswell Park Cancer Institute
Grupo Espanol de Investigacion en Sarcomas
Swiss Cancer Institute
South Plains Oncology Consortium